Chief Physician, Dr., Doctoral Supervisor, Deputy Director of the Department of Hematology II, Beijing Children's Hospital, Capital Medical University, and Head of the Histiocytic Diseases Professional Group at Beijing Children's Hospital.
Affiliated HospitalBeijing Children's Hospital (School of Pediatrics, National Children's Medical Center), Capital Medical University
→
Dedicated to the diagnosis, treatment, and research of rare pediatric hematologic diseases, specializing in various pediatric histiocytic diseases, including individualized stratified treatment for Langerhans cell histiocytosis (LCH) and hemophagocytic lymphohistiocytosis (HLH), treatment of refractory and relapsed histiocytic diseases, and diagnosis and treatment of chronic active Epstein-Barr virus (EBV) infection. He pioneered the "individualized stratification regimen based on ruxolitinib treatment response" for HLH treatment internationally. He is the Deputy Head of the National Pediatric EBV Infection Collaborative Group, Secretary of the Hematology Group of the Chinese Medical Association Pediatrics Branch, Secretary of the Expert Committee on Pediatric Hematologic Diseases of the National Health Commission, a member of the Beijing Hemophagocytic Lymphohistiocytosis Collaborative Group, a member of the International Histiocytic Society, and a member of the Histiocytic Diseases Professional Committee of the Hematology Branch of the Chinese Medical Doctor Association.